Clinical Trial Update: Phase II Trial With Metronomic, Capecitabine Plus Oral Vinorelbine for Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

A Phase II clinical trial evaluating metronomic capecitabine in combination with oral vinorelbine for metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Navelbine (vinorelbine)
• Xeloda (capecitabine)

Snippet

Sponsor: University of Aarhus | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED